Taro Pharmaceutical
TARO
$42.82
Share price
0.33%
Change (1 day)
12.15%
Change (1 year)
Categories
Taro Pharmaceutical (TARO) Fails to deliver data
Key failure to deliver metrics for Taro Pharmaceutical:
- Last SEC data release: 2024-05-14
- Last 15 days FTD volume: $0 M
- Last 3 months FTD volume: $0.14 M
- Last year FTD volume: $1.56 M
Failures to deliver for Taro Pharmaceutical (TARO) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Taro Pharmaceutical (TARO) - since 2013
Volume in USD (price x number of shares), data since 2013Taro Pharmaceutical (TARO) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.15 M | -89.88% |
| 2023 | $1.57 M | -47.83% |
| 2022 | $3.01 M | 40.95% |
| 2021 | $2.13 M | -20.4% |
| 2020 | $2.68 M | -63.93% |
| 2019 | $7.45 M | -59.37% |
| 2018 | $18.33 M | -63.34% |
| 2017 | $50.02 M | -66.2% |
| 2016 | $0.14 B | 490.84% |
| 2015 | $25.04 M | 261.06% |
| 2014 | $6.93 M | 220.75% |
| 2013 | $2.16 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $28.5 M | $0.59 B | 🇺🇸 USA |
 Novartis NVS | $20.77 M | $81.53 M | 🇨🇭 Switzerland |
 Pfizer PFE | $13.91 M | $0.31 B | 🇺🇸 USA |
 Merck MRK | $5.8 M | $0.14 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $17.9 M | $24.11 M | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $0.84 M | $25.76 M | 🇮🇱 Israel |